A Study to Analyze Biopsy of Vascular Malformations


About this study

The purpose of this study is to validate a core biopsy technique for obtaining tissue from treatment naive vascular anomalies for clinical pathology and genomic analyses in patients undergoing clinically indicated sclerotherapy, embolization and/or ablation.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients with a clinical and imaging diagnosis of a vascular anomaly.
  • No prior treatment for the vascular anomaly.
  • Subjects undergoing clinically indicated sclerotherapy, embolization and/or ablation.
  • Male or female with age greater than or equal to 18 years.
  • Capacity and willingness to provide a written informed consent..

Exclusion Criteria:

  • Subjects with prior treatment for their vascular anomaly.
  • Uncorrectable coagulopathy.
  • Pregnant and/or breast-feeding subjects. A negative pregnancy test within 48 hours of the procedure.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Emily Bendel, M.D.

Closed for enrollment

Contact information:

Emily Bendel M.D.

(507) 255-7131


More information


Publications are currently not available

Mayo Clinic Footer